Koers Hubei Biocause Pharmaceutical Co., Ltd.
Aandelen
000627
CNE000000F48
Levens- en ziektekostenverzekering
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,45 CNY | +1,24% | -5,77% | -13,73% |
Omzet 2021 | 48,7 mld. 6,74 mld. 6,25 mld. | Omzet 2022 | 49,31 mld. 6,82 mld. 6,32 mld. | Marktkapitalisatie | 15,61 mld. 2,16 mld. 2 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 471 mln. 65,18 mln. 60,4 mln. | Nettowinst (verlies) 2022 | 274 mln. 37,92 mln. 35,14 mln. | EV/omzet 2021 | 0,18 x |
Nettoliquiditeiten 2021 | 7,58 mld. 1,05 mld. 972 mln. | Nettoschuld 2022 | 1,76 mld. 244 mln. 226 mln. | EV/omzet 2022 | 0,35 x |
K/w-verhouding 2021 |
33,1
x | K/w-verhouding 2022 |
52,7
x | Werknemers | 2.098 |
Dividendrendement 2021 |
0,15% | Dividendrendement 2022 |
3,48% | Vrij verhandelbaar | 31,71% |
1 dag | +1,24% | ||
1 week | -5,77% | ||
Lopende maand | -9,93% | ||
1 maand | -9,59% | ||
3 maanden | -10,91% | ||
6 maanden | -22,22% | ||
Lopend jaar | -13,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wen Xia Zhou
CEO | Chief Executive Officer | 52 | 26-05-20 |
Jian Qiang Shen
CHM | Chairman | 52 | 01-06-96 |
Da Li Chen
DFI | Director of Finance/CFO | 57 | 26-05-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yi Qian Liu
CHM | Chairman | 61 | 11-03-15 |
Yunhua Xiao
BRD | Director/Board Member | 62 | 01-04-03 |
Da Li Chen
DFI | Director of Finance/CFO | 57 | 26-05-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 2,45 | +1,24% | 15 663 480 |
27-03-24 | 2,42 | -2,42% | 18 919 400 |
26-03-24 | 2,48 | -0,40% | 19 505 420 |
25-03-24 | 2,49 | -2,35% | 19 194 320 |
22-03-24 | 2,55 | -2,67% | 27 284 600 |
slotkoers Shenzhen S.E., 28 maart 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-13,73% | 1,65 mld. | |
+18,06% | 82,58 mld. | |
+12,07% | 53,45 mld. | |
+4,07% | 49,27 mld. | |
+13,20% | 42,03 mld. | |
+22,80% | 40,35 mld. | |
+7,55% | 31,7 mld. | |
-1,23% | 29,47 mld. | |
-16,25% | 26,12 mld. | |
+28,68% | 24,84 mld. |